Register to apply
for a grant
Log in to manage
your applications
 
 

Fellowship news


Throughout the year we will share the latest news in HIV, viral hepatitis, oncology/haematology, respiratory and invasive fungal disease, which will include updates from projects supported by the Gilead UK & Ireland Fellowship Programme and any key successes (eg posters, publications) arising from projects supported in previous years.

 

February 03 2015

Hepatitis C Coalition published ‘vision for hepatitis C’ report

 

In November 2014 the Hepatitis C Coalition published its future vision for hepatitis C in the UK, calling on the government to improve services to prevent further unnecessary deaths. The report titled ‘A Vision for Change in Hepatitis C’, worked with leading hepatitis C clinicians, patients and professional groups and shows that  deaths from the disease have quadrupled since 1996. It warns that without earlier identification and treatment the burden of end-stage liver disease, liver cancer and liver disease deaths from hepatitis C will continue to grow for at least the next 20 years.

In response to this publication, Dr Paul Cosford, Director of the Health Protection Agency and Medical Director at Public Health England, said: “With around 160,000 people in England living with chronic hepatitis C, there is an urgent need to scale up our response and prevent more deaths and serious illness.” Recent advances in medicines have led some experts to predict that hepatitis C could be eliminated in the UK by 2030. Chair of the Coalition, Professor Mark Thursz, a Consultant Hepatologist at St Mary’s Hospital, said: “We are in a very fortunate position to have cost-effective treatments that will cure the majority of hepatitis C patients but we need to find these patients and treat them.”

The Hepatitis C Coalition set out eight recommendations within the report, including the need for the development of a clear national implementation plan, improvements in diagnosis and screening and timely access to approved medicines. Next steps involve appealing to the Department of Health to take responsibility for the implementation plan.

Please visit www.hepc-coalition.uk/manifesto.php for more information and videos outlining the call to action.

Posted by: Website administrator

February 03 2015

“We can eliminate hepatitis C within our lifetime”, message from EU experts at Five Nations conference

 

European experts attending the inaugural Five Nations conference on HIV and Hepatitis have called for a global effort on eliminating hepatitis C. The Five Nations Conference on HIV and Hepatitis took place on 8–9 December 2014 in London and was an opportunity for Europe's leading hepatitis and HIV experts to share research and discuss priorities for research, treatment and care to meet the global challenge of viral hepatitis and liver disease in the context of HIV disease.

Among ten issues addressed in a landmark statement by clinicians from France, Germany, Italy, Spain and the UK, together with their community partners, the European AIDS Treatment Group, is an appeal to governments, the pharmaceutical industry and the medical profession to co-operate in making the latest generation of effective antiviral treatments for hepatitis C affordable and accessible to all patients.

The group also calls on world leaders to use lessons learned from HIV and AIDS as a model for raising awareness of HCV, testing for infection, and building on the existing HIV treatment infrastructure to reduce the number of deaths from HCV-related end-stage liver disease and liver cancer. With new antiviral treatments for HCV working well, both for patients with and without HIV, European experts are also calling for people with HIV to receive these treatments as a priority.

Dr Ranjababu Kulasegaram, Chair of the British HIV Association Hepatitis Society Subcommittee, said: "On the 25th anniversary of the discovery of HCV, we have reached a turning point in our ability to treat the infection, with revolutionary new drugs that offer real hope of eradicating this pernicious, often hidden disease. Despite their effectiveness, however, these treatments will have little value for the majority of people with HCV, unless their costs are drastically reduced and they are made universally accessible.“

Dr Mark Nelson, Chair of the Five Nations conference programme, said: "We know preventing transmission of the infection is possible, through a range of measures including needle exchange and opiate substitution therapy programmes for people who inject drugs, and education campaigns to prevent sexual transmission, particularly among men who have sex with men. We strongly urge governments, the pharmaceutical industry, clinicians, community organisations and non-governmental organisations to work together to make global elimination of HCV a realistic target within our lifetime.“

To view the presentations and post-conference report please click here.

Posted by: Website administrator

February 03 2015

New fungal education tool released: ‘CARE Fungal KnowledgeBank’

 

A new fungal education tool has been developed jointly by the University of Manchester and Gilead Sciences Europe Ltd and released as an iPad app: CARE Fungal KnowledgeBank.

CARE is an educational initiative for clinicians, scientists and other healthcare professionals working in the field of fungal infections. It comprises training modules offering a comprehensive and logical flow through fungal diseases and their management.

Management of fungal infections is a specialised and evolving area. There have been unprecedented changes in the pattern of fungal infections and their management over the past two decades. Invasive fungal infections are increasing in incidence, particularly in patients with compromised immune systems. Advances in healthcare practices and an increasing ageing population are driving emergence of new ‘at risk’ patient populations while diagnosis, treatment and prevention are evolving to reflect these changes.

The CARE programme was created with the support of Gilead Sciences Europe Ltd who also provided funding for this educational initiative.

To download this resource please click here

Posted by: Website administrator

February 03 2015

25th ESCMID Conference open for registration

 

The 25th European Society of Clinical Microbiology and Infectious Diseases, will be held from 25–28 April 2015 in Copenhagen, Denmark. Registration is currently open and the preliminary programme is available to view on the event website.

 

For more information please click here

Posted by: Website administrator

February 03 2015

UK Government confirms that it will not cut the HIV prevention budget

 

The Government has refuted claims that it was to halve its HIV prevention budget for 2015, reiterating support for the strategy and saying “It [funding] will continue”. Charities spoke out against apparent plans to slash funding for HIV Prevention England, which focusses on reducing HIV transmission in gay and bisexual men and ethnic minorities, from £2.45m to £1.2m from April 2015. A petition allowed users to lobby the Government to reconsider the cut and to maintain the current level of funding to prevent HIV transmission for the next 3 years.

In a letter from Health Minister Jane Ellison to Tory MPs Mike Freer and Simon Kirby, sent to PinkNews, she refuted claims that the fund would be slashed, and guaranteed that the money “will continue”. She wrote: “I want to take this opportunity to make absolutely clear that this Government will protect funding for HIV prevention. Suggestions that we are going to cut this provision are unfounded. It will continue.”

For the full story please click here 

Posted by: Website administrator

February 03 2015

HIV in the UK: 2014 report from Public Health England

 

Public Health England’s 2014 report for HIV statistics in the UK highlights the need to increase both the number and the frequency of HIV tests. There are now nearly 110,000 people living with HIV in the UK. Around a quarter of these (26,100) are unaware of their infection and at risk of passing on the virus to others through unprotected sex. Encouragingly, the proportion of people diagnosed with late stage HIV infection fell from 57% in 2004 to 42% in 2013.

The report shows around 6% of gay and bisexual men are now living with HIV, rising to 13% in London, with 3,250 newly diagnosed cases in 2013, an all-time annual high. It is estimated that over 7,000 gay men have an HIV infection that remains undiagnosed and that an estimated 2,800 men acquired HIV in 2013. These figures underline the need to further increase both the numbers and frequency of HIV tests, which are critical to tackling the ongoing high levels of HIV transmission.

Whilst the majority of black Africans are not infected with HIV, the report also draws attention to the fact that approximately one-third of the 40,000 black African heterosexual men and women living with HIV in the UK do not know they have HIV.

To view the full report please click here

Posted by: Website administrator

February 03 2015

21st Annual Conference of the British HIV Association

 

The 21st Annual Conference of the British HIV Association will take place on 21–24 April 2014 in Brighton, UK. Chaired by a past Fellowship grant awardee, Dr David Asboe, the conference will include oral research presentations from healthcare professionals, with a focus on research and other work in the UK.

Registration is currently open; for more information please click here.

Posted by: Website administrator

February 03 2015

Launch of Immuno-Oncology Policy Action Framework

 

Recent findings with therapies that use the body’s immune system to fight cancer (immuno-oncology therapies) have fuelled hope for the first time that long-term, quality survival may now be possible for patients with many forms of advanced cancer.

ON 19 November 2014, the European Cancer Patient Coalition (ECPC) launched the document ‘Immuno-Oncology: a Policy Action framework’, and a guide for patients on what immuno-oncology is, within the European Parliament.

For more information please click here

Posted by: Website administrator

February 03 2015

British Society For Haematology 55th Annual Scientific Meeting

 

The 55th Annual Scientific Meeting of the British Society For Haematology (BSH) will take place on 20–22 April 2015 in Edinburgh. Registration is currently open on the event website.

The theme for 2015 is ‘Improving Outcomes’ and will be an opportunity for a comprehensive update on advances in haematology and changing clinical and laboratory practices.

Posted by: Website administrator

February 03 2015

38th European Cystic Fibrosis Conference

 

Registrations and abstract submissions are now open for the 38th European Cystic Fibrosis Conference taking place in Brussels, Belgium, from
10–13 June 2015.

Please click here to visit the event website 

Posted by: Website administrator

 
 

Register your interest

The Gilead UK & Ireland Fellowship Programme is now closed for applications. Please register your interest for the 2018 programmes here.

 
 
 
EXTERNAL POPUP